LY3415244

LY3415244 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3415244, covering 2021-08-31 to 2021-08-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3415244 in Participants With Advanced Solid Tumors [Phase 1]